SPHK1 and posterior cortical atrophy: Also, recent studies demonstrate that SPHK1/S1PRs-targeting treatment can have a significant impact on PCa cell growth [166], angiogenesis [167], chemotherapy resistance [164,165,168,169,170], radiotherapy resistance [171], migration and invasion [172].